| OCLVX | VIVIX | OCLVX / VIVIX | |
| Total Expense Ratio | 1.92 | 0.03 | 6,400% |
| Annual Report Gross Expense Ratio | 1.92 | 0.03 | 6,400% |
| Fund Existence | 23 years | 28 years | - |
| Gain YTD | 12.206 | 15.125 | 81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.94B | 254B | 1% |
| Annual Yield % from dividends | 0.00 | 1.86 | - |
| Returns for 1 year | 13.01 | 24.28 | 54% |
| Returns for 3 years | 12.61 | 50.26 | 25% |
| Returns for 5 years | 6.06 | 58.89 | 10% |
| Returns for 10 years | 42.64 | 154.95 | 28% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BSMQ | 23.55 | 0.01 | +0.04% |
| Invesco BulletShares 2026 Muncpl Bd ETF | |||
| GTOH | 25.22 | N/A | N/A |
| Invesco Short Duration High Yield ETF | |||
| YQQQ | 10.18 | -0.03 | -0.25% |
| YieldMax Short N100 Option Inc Strgy ETF | |||
| AZTD | 32.26 | -0.28 | -0.85% |
| Aztlan Global Stock Sel Dm SMID ETF | |||
| ARKG | 38.56 | -0.70 | -1.78% |
| ARK Genomic Revolution ETF | |||